Black Diamond Therapeutics (BDTX)
US Market

Black Diamond Therapeutics (BDTX) Financial Statements


Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.127; its P/E ratio is -2.21; Black Diamond Therapeutics is scheduled to report earnings on March 26, 2024, and the estimated EPS forecast is $-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 334.00K$ 335.00K$ 135.00K-$ 0.00
Gross Profit$ 334.00K$ 335.00K$ 135.00K--
EBIT$ -23.01M$ -19.15M$ -20.88M$ -21.08M$ -22.12M
EBITDA$ -22.89M$ -19.04M$ -20.75M$ -20.42M$ -22.00M
Net Income Common Stockholders$ -23.01M$ -19.15M$ -20.88M$ -21.08M$ -21.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 144.26M$ 89.53M$ 103.37M$ 122.81M$ 144.18M
Total Assets$ 172.38M$ 119.88M$ 135.58M$ 156.25M$ 180.42M
Total Debt$ 23.00M$ 23.78M$ 24.55M$ 25.30M$ 28.82M
Net Debt$ -121.26M$ -65.75M$ -78.82M$ -97.51M$ -115.36M
Total Liabilities$ 38.06M$ 37.68M$ 37.39M$ 40.56M$ 47.19M
Stockholders Equity$ 134.32M$ 82.20M$ 98.19M$ 115.69M$ 133.23M
Cash Flow-
Free Cash Flow$ -18.39M$ -14.27M$ 1.17M-$ -16.47M
Operating Cash Flow$ -18.36M$ -14.37M$ 1.17M-$ -16.48M
Investing Cash Flow$ -37.88M$ 17.18M$ 24.81M-$ 14.51M
Financing Cash Flow$ 71.93M-$ 51.00K-$ 52.00K
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis